SCHEMBL9312600

SCHEMBL9312600

O=Cc1ccc(OCCc2ccc3c(n2)CCCC3)cc1

nearest known ligand 0.43

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
LMNA P02545 2/20 0.43
HPGD P15428 2/20 0.43
MAPT P10636 1/20 0.43
ITGB3 P05106 12/20 0.42
ITGAV P06756 12/20 0.42
ITGB6 P18564 6/20 0.42
ITGB5 P18084 4/20 0.41
ITGB1 P05556 2/20 0.41
ITGA2B P08514 1/20 0.40
KDM4E B2RXH2 1/20 0.38
RAB9A P51151 1/20 0.37
ITGA5 P08648 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9312021 0.81 HPGD (0.61) HPGD
SCHEMBL9312031 0.79 HPGD (0.48) HPGD
SCHEMBL5413870 0.74 PPARG (0.58) ALDH1A1SMN1; SMN2LMNAHPGDMAPT
SCHEMBL9430175 0.73 PPARG (0.40) HPGDITGB3ITGAVITGB6ITGB5
SCHEMBL9430167 0.73 PPARG (0.62) ALDH1A1HPGDMAPT
SCHEMBL8800183 0.72 CYSLTR1 (0.51) ALDH1A1SMN1; SMN2KDM4ERAB9A
SCHEMBL8196269 0.70 SMN1; SMN2 (0.48) ALDH1A1SMN1; SMN2LMNAHPGDMAPT
SCHEMBL30599264 0.69 HPGD (0.64) ALDH1A1SMN1; SMN2LMNAHPGDMAPT
SCHEMBL3258559 0.69 HPGD (0.64) ALDH1A1SMN1; SMN2LMNAHPGDMAPT
SCHEMBL9312593 0.69 ALDH1A3 (0.45) ALDH1A1SMN1; SMN2LMNAHPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5330999-A Diabetes, obesity ADIR ET COMPAGNIE (FR) 1994-07-19 US disclosed
US-5296605-A 2,4-thiazolidinedione compounds ADIR ET COMPAGNIE (FR) 1994-03-22 US disclosed
US-5266582-A Antidiabetic agents ADIR ET COMPAGNIE (FR) 1993-11-30 US disclosed
EP-0528734-A1 Thiazolidin-2,4-dione derivatives, process for their preparation and pharmaceutical compositions containing them ADIR ET COMPAGNIE (FR) 1993-02-24 EP disclosed